Mayur Maheshwari, CEO of UPSIDA, said the Bulk Drug Pharma Park would be important in reducing India's dependence on China for bulk drug production. A total of 26 companies have expressed interest so ...

Dr. Reddy's Labs ADR saw both earnings and sales growth rise last quarter. Earnings-per-share increased from 0% to 16%.

Dr. Crystal Truong and Dr. Vish Reddy opened the doors to Apex Eye in Frisco with a clear mission to create an ophthalmology ...

Telangana Irrigation Minister Capt N Uttam Kumar Reddy reaffirmed the state government’s determination to resist Andhra Pradesh’s proposed Godavari-Banakacharla Link Project, calling it a blatant ...

Ontario, Calif.-based Prime Healthcare realigned services at Illinois hospitals it recently acquired from St. Louis-based Ascension, citing unsustainable financial losses and low patient volumes that ...

Dr. Reddy's Laboratories Ltd. closed 7.02% short of its 52-week high of 1,420.20 rupees, which the company achieved on August ...

Dr. Reddy’s Laboratories has partnered with global biotech firm Alvotech to co-develop and commercialize a biosimilar of ...

Dr. Reddy's Laboratories Ltd marked a 5.4% change today, compared to -0.0% for the S&P 500. Is it a good value at today's ...

Alvotech and Dr. Reddy's will co-develop a biosimilar to Keytruda, aiming to expand global access to cancer treatment alternatives.

Dr. Reddy's Laboratories Ltd. Sponsored ADR (RDY) is currently at $15.62, up $0.88 or 5.93% --Would be highest close since Jan. 8, 2025, when it closed at $15.81 --On pace for largest percent increase ...

Alvotech (ALVO) and Dr. Reddy’s Laboratories (RDY) have entered into a collaboration and license agreement to co-develop, ...

Dr. Reddy's Laboratories Ltd. closed 9.17% short of its 52-week high of 1,420.20 rupees, which the company reached on August ...